Medication info
Rabeanu Tablet 20/500 mg

Rabeanu Tablet 20/500 mg

Prescription medicationTabletOral
Ingredient · strength
Sodium Bicarbonate›500mg / 1 tabletRabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
Brownish-yellow oval film-coated tablet
Packaging
28 tablets/bottle
Approval status
Active

MFDS item code 202200467 · Approved 2022.01.27 · Insurance code 642405000

Summary

Main use
Treatment, symptom relief, and maintenance treatment of gastroesophageal reflux disease; treatment of gastric and duodenal ulcers
Who takes it
Adults · Children
Adult dose
Although this medicine contains 10 mg and 20 mg of rabeprazole sodium in the 10/500mg and 20/500mg strengths, respectively, note that the amount of sodium bicarbonate in 2 tablets of 10/500mg is not the same as that in 1 tablet of 20/500mg. 1) Gastric ulcer and duodenal ulcer: The usual adult dose is 10/500mg orally once daily. Depending on symptoms, 20/500mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: Administer 10/500mg or 20/500mg once daily for 4~8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10/500mg or 20/500mg may be administered orally twice daily for an additional 8 weeks. However, 20/500mg twice daily is restricted to patients with confirmed severe mucosal damage. 3) Relief of symptoms of gastroesophageal reflux disease: Administer 10/500mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10/500mg once daily. 4) Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10/500mg or 20/500mg orally once daily, depending on the patient. Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Use with caution because liver function is often impaired.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment, symptom relief, and maintenance treatment of gastroesophageal reflux disease; treatment of gastric and duodenal ulcers

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
View approved original text

This medication is effective in the treatment of gastric and duodenal ulcers, and is used to improve erosive or ulcerative lesions caused by gastroesophageal reflux disease. It also alleviates the symptoms of gastroesophageal reflux disease and assists in long-term maintenance therapy. For these reasons, it is useful in improving inflammation and ulceration of the stomach and esophagus.

How to take

Adult dose

Although this medicine contains 10 mg and 20 mg of rabeprazole sodium in the 10/500mg and 20/500mg strengths, respectively, note that the amount of sodium bicarbonate in 2 tablets of 10/500mg is not the same as that in 1 tablet of 20/500mg. 1) Gastric ulcer and duodenal ulcer: The usual adult dose is 10/500mg orally once daily. Depending on symptoms, 20/500mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: Administer 10/500mg or 20/500mg once daily for 4~8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10/500mg or 20/500mg may be administered orally twice daily for an additional 8 weeks. However, 20/500mg twice daily is restricted to patients with confirmed severe mucosal damage. 3) Relief of symptoms of gastroesophageal reflux disease: Administer 10/500mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10/500mg once daily. 4) Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10/500mg or 20/500mg orally once daily, depending on the patient. Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Use with caution because liver function is often impaired.

Child dose

Safety in children has not been established.

Precautions

This medication should not be administered to certain patients. Patients who are allergic to this drug or any of its components or have had hypersensitivity reactions should not use it. Additionally, it should not be given to patients taking atazanavir or rilpivirine, and to women who are pregnant or breastfeeding. Patients with liver dysfunction, impaired kidney function, the elderly, and those with poor heart or lung function should use this drug cautiously. Particular care is required for those with electrolyte imbalances or who need to limit sodium intake. During the course of treatment, allergic reactions such as skin rash, hives, or itching may occur, so if symptoms arise, discontinue use immediately. Regular blood tests are recommended as changes in red or white blood cell counts or increased liver function tests may occur. Various side effects such as cardiac-related abnormal symptoms, gastrointestinal symptoms, headaches, dizziness, shortness of breath, muscle pain, and joint pain may arise, so it is essential to consult with healthcare professionals if any abnormal symptoms occur. This medication suppresses gastric acid secretion, which may increase the risk of osteoporosis-related fractures with long-term use. Additionally, hypomagnesemia can occur due to lowered magnesium levels, so regular monitoring of serum magnesium concentrations is needed when taking this for an extended period or in conjunction with specific medications. With a decrease in gastric acid, the risk of gastrointestinal bacterial infections may slightly increase, and if diarrhea symptoms persist, Clostridium difficile infection should be suspected. This medication does not significantly affect driving or machine operation, but caution is needed due to possible drowsiness. There may be interactions when this drug is combined with other medications, so it is crucial to inform the medical staff about any other medicines being taken, particularly with warfarin, methotrexate, atazanavir, or rilpivirine, which should be used cautiously or not at all. It should not be used in pregnant or breastfeeding women, and caution is required for the elderly due to the higher incidence of side effects from liver function deterioration. These tablets should be swallowed whole without chewing or crushing and must be kept out of reach of children. With long-term use, there may be the potential for symptoms of malignant tumors to be masked or diagnoses to be delayed, so consult healthcare professionals for any abnormal symptoms. Additionally, the risk of gastric polyps may increase with prolonged use; therefore, it is advised to maintain the treatment duration and dosage at minimal levels. No specific antidote exists for overdose, but appropriate treatment should be administered based on symptoms, and regular blood and liver function tests are advisable.

Side effects

  • Rash
  • hives
  • itching
  • erythrocytopenia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • neutrophilia
  • lymphocytopenia
  • anemia
Show 167 more
  • petechiae
  • lymphadenopathy
  • hypochromic anemia
  • pancytopenia
  • agranulocytosis
  • thrombocytopenia
  • hemolytic anemia
  • elevated ALT
  • elevated AST
  • elevated ALP
  • elevated γ-GTP
  • elevated LDH
  • elevated total bilirubin
  • fulminant hepatitis
  • liver dysfunction
  • jaundice
  • hypertension
  • myocardial infarction
  • ECG abnormalities
  • migraines
  • syncope
  • angina
  • heart block
  • palpitations
  • bradycardia
  • tachycardia
  • pulmonary embolism
  • ventricular tachycardia
  • thrombophlebitis
  • vasodilation
  • QTc prolongation
  • ventricular tachycardia
  • diarrhea
  • constipation
  • abdominal pain
  • abdominal distension
  • dyspepsia
  • belching
  • nausea
  • rectal bleeding
  • blood in stools
  • anorexia
  • cholelithiasis
  • oral ulcers
  • dysphagia
  • gingivitis
  • cholecystitis
  • increased appetite
  • abnormal stools
  • colitis
  • esophagitis
  • glossitis
  • pancreatitis
  • proctitis
  • thirst
  • vomiting
  • lower abdominal pain
  • gastric body
  • gastritis
  • stomatitis
  • dysgeusia
  • hemorrhagic diarrhea
  • cholangitis
  • duodenitis
  • gastrointestinal bleeding
  • hepatic encephalopathy
  • hepatitis
  • liver cancer
  • hepatic steatosis
  • salivary gland enlargement
  • thirst
  • headache
  • insomnia
  • anxiety
  • dizziness
  • convulsions
  • abnormal dreams
  • decreased libido
  • neuropathy
  • sensory abnormalities
  • tremors
  • weakness
  • neuroexcitation
  • drowsiness
  • lightheadedness
  • depression
  • agitation
  • amnesia
  • confusion
  • extrapyramidal syndrome
  • hypervolemia
  • limb hypotonia
  • perceptual disturbance
  • decreased grip strength
  • language confusion
  • staggering
  • delirium
  • disorientation
  • hypersomnia
  • coughing
  • pharyngitis
  • rhinitis
  • dyspnea
  • asthma
  • epistaxis
  • laryngitis
  • hiccups
  • hyperventilation
  • bronchitis
  • sinusitis
  • apnea
  • respiratory depression
  • interstitial pneumonia
  • myalgia
  • low back pain
  • arthritis
  • leg cramps
  • bone pain
  • arthrosis
  • bursitis
  • hypertonicity
  • neuralgia
  • single contraction
  • sweating
  • alopecia
  • dryness of skin
  • shingles
  • psoriasis
  • skin color changes
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • cataracts
  • amblyopia
  • glaucoma
  • dry eyes
  • abnormal vision
  • tinnitus
  • otitis media
  • corneal opacity
  • blurriness
  • diplopia
  • hearing loss
  • eye pain
  • retinal degeneration
  • strabismus
  • proteinuria
  • cystitis
  • frequent urination
  • dysmenorrhea
  • urinary difficulties
  • nephrolithiasis
  • uterine bleeding
  • polyuria
  • gynecomastia
  • elevated thyroid-stimulating hormone
  • Clostridium difficile diarrhea
  • systemic lupus erythematosus
  • cutaneous lupus erythematosus
  • halitosis
  • xerostomia
  • chest tightness
  • allergic reactions
  • hypertriglyceridemia
  • hypercholesterolemia
  • palpitations
  • increased intraocular pressure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. The storage temperature should be kept between 1 to 30 degrees Celsius at room temperature, and it is advisable to avoid places that are too hot or too cold.

Appearance and packaging

Appearance

Brownish-yellow oval film-coated tablet

Package unit

28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.